Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Johnson & Johnson

TRADE

NYSE: JNJHealthcare / Drug Manufacturers - Major / USA
134.47+1.99+1.50%Vol 6 635 9611Y Perf 1.07%
Aug 17th, 2018 16:00
BID134.32 ASK135.00
Open132.45 Previous Close132.48
Pre-Market132.47 After-Trading134.33
 -0.01 -0.01%  -0.14 -0.10%
Target Price
146.00 
Analyst Rating
Moderate Buy 2.00
Potencial %
8.57 
Finscreener Ranking
+     37.11
Insiders Trans % 3/6/12M
-/-/-100 
Value Ranking
     37.22
Insiders Value % 3/6/12M
-/-/-100 
Growth Ranking
★+     42.92
Insiders Shares Cnt. % 3/6/12M
-/-/-100 
Income Ranking
★★     43.13
Market Cap (mil)360 770 
Earnings Rating
Price Range Ratio 52wk %
53.37 
Earnings Date

Today's Price Range

132.19135.00

52wk Range

118.62148.32

5 Year PE Ratio Range

14.3024.90

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
2.61%
3 Months
6.97%
6 Months
-0.50%
1 Year
1.07%
3 Years
34.65%
5 Years
59.15%

Quotes

Name / TickerPriceChg.Chg.%
JNJ134.471.99001.50
AAPL217.584.26002.00
GOOG1 200.96-5.5300-0.46
MSFT107.58-0.0600-0.06
XOM78.260.26000.33
WFC58.860.20000.34
FB173.80-0.9000-0.52
GE12.300.00000.00
JPM114.770.00000.00
 
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.20
Current Ratio 1.70
Long Term Debt to Total Capital 0.32
Total Debt to Equity 0.51
Interest Coverage 18.50
Leverage Ratio 2.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin65.70
EBIT Margin23.30
EBITDA Margin32.10
Pre-tax Profit Margin25.50
Profit Margin1.70
ValuationValueIndustryS&P 500US Markets
PE Ratio 251.40
PB Ratio 5.58
PS Ratios 4.35
Price to Cash Flow 16.20
Price to Free Cash Flow 43.80
Cash Flow Per Share 8.06
Price to Tangible Book-20.03
Book Value per Share23.44
Enterprise Value (in ths.)364 714 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)18.23
ROE last 12 Months 2.04
Return on Assets (5Y Avg) 8.23
ROA last 12 Months 0.89
Return on Capital (5Y Avg) 14.33
ROC last 12 Months 1.41
Return on invested Capital Q 4.24
Return on invested Capital Y1.39
Assets Turnover0.20
Receivables Turnover2.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)80 684 000
Revenue per Share 30.08
Revenue Growth 3 Years 3.43
Revenue Growth 5 Years 1.69
DividendsValueIndustryS&P 500US Markets
Dividend Yield 2.76
Dividend Rate 3.60
Dividend Growth 3 Years5.14
Dividend Growth 5 Years5.99

Earnings HistoryEstimateReportedSurprise %
Q02 20182.062.101.94
Q01 20182.012.062.49
Q04 20171.721.741.16
Q03 20171.801.905.56
Q02 20171.791.832.23
Q01 20171.771.833.39
Q04 20161.561.581.28
Q03 20161.651.681.82
Earnings Per EndEstimateRevision %Trend
6/2018 QR2.06-0.48Negative
9/2018 QR2.04-0.97Negative
12/2018 FY8.130.25Positive
12/2019 FY8.640.23Positive
Next Report Date17th Jul 2018
Estimated EPS Next Report2.06
Estimates Count8
EPS Growth Next 5 Years %8.00
Volume Overview
Volume6 635 961
Shares Outstanding (in ths.)2 682 900
Trades Count29 377
Dollar Volume724 403 204
Avg. Volume7 163 208
Avg. Weekly Volume5 638 700
Avg. Monthly Volume6 047 605
Avg. Quarterly Volume6 510 284

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

77%23%

Bearish Bullish

51%49%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (43.75 %)
7 (38.89 %)
8 (44.44 %)
Moderate Buy
2 (12.50 %)
2 (11.11 %)
2 (11.11 %)
Hold
7 (43.75 %)
7 (38.89 %)
6 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
2 (11.11 %)
2 (11.11 %)
RatingModerate Buy
2.00
Moderate Buy
2.33
Moderate Buy
2.22

There are no comments yet.

News

x